BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 16 filers reported holding BETTER THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $22,608 | -53.7% | 58,600 | +29.6% | 0.00% | – |
Q2 2023 | $48,816 | +48.3% | 45,200 | 0.0% | 0.00% | – |
Q1 2023 | $32,906 | -67.5% | 45,200 | -50.0% | 0.00% | – |
Q4 2022 | $101,248 | +26.6% | 90,400 | +100.0% | 0.00% | – |
Q3 2022 | $80,000 | +12.7% | 45,200 | 0.0% | 0.00% | – |
Q2 2022 | $71,000 | +14.5% | 45,200 | +239.2% | 0.00% | – |
Q4 2021 | $62,000 | – | 13,327 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $1,560,000 | 0.01% |
Tower Research Capital LLC (TRC) | 14,627 | $23,000 | 0.00% |
TWO SIGMA INVESTMENTS, LP | 73,800 | $115,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 65 | $0 | 0.00% |
NORTHERN TRUST CORP | 16,703 | $26,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 37,944 | $59,000 | 0.00% |
STATE STREET CORP | 45,200 | $71,000 | 0.00% |
MORGAN STANLEY | 93,973 | $147,000 | 0.00% |
BlackRock Inc. | 75,948 | $118,000 | 0.00% |